Sam Bankman-Fried isn't going down without a fight. The disgraced FTX founder on Tuesday pleaded not guilty on all counts, including multiple charges of fraud and conspiracy.
Bankman-Fried, 30, is going a different route than his co-executives at FTX: Gary Wang, co-founder of FTX, and Caroline Ellison, CEO of Alameda Research, have both pleaded guilty.
Indeed, there is widespread consensus that FTX's leadership engaged in criminal activity. Even current CEO John J. Ray III has described the situation as "old-fashioned embezzlement."
The U.S. attorney of the Southern District of New York filed the charges in December, along with parallel actions from the Securities and Exchange Commission (SEC) and the Commodity Futures Trading Commission (CFTC).
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
